Biomedical Computer Technologies NyRt. (FRA:BCT) Debt-to-EBITDA : -4.11 (As of Jun. 2021)

Biomedical Computer Technologies NyRt. Debt-to-EBITDA Chart

Biomedical Computer Technologies NyRt. Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
Debt-to-EBITDA		Get a 7-Day Free Trial					-0.44	-2.70	1.49	1.39	6.82

Biomedical Computer Technologies NyRt. Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.47	0.60	1.26	41.36	-4.11

Competitive Comparison of Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA

For the Specialty Industrial Machinery subindustry, Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA falls into.

Biomedical Computer Technologies NyRt. Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Biomedical Computer Technologies NyRt.'s annualized Debt-to-EBITDA for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2021) EBITDA data.

Biomedical Computer Technologies NyRt.  (FRA:BCT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Biomedical Computer Technologies NyRt. Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biomedical Computer Technologies NyRt.'s Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomedical Computer Technologies NyRt. (FRA:BCT) Business Description